Pharmacokinetics, Dialysability and Safety of HRS-9231 in Healthy Volunteers and in Patients With Impaired Renal Function

Clinical trial NCT06657560 · COMPLETED

Trial details

NCT number: NCT06657560
Sponsor: Shanghai Shengdi Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Contrast-Enhanced Magnetic Resonance Imaging Detection

Start date: 2024-10-14
Primary completion: 2025-07-03
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.